A safety mechanism enables tissue-specific resistance to protein aggregation during aging in C. elegans.

During aging, proteostasis capacity declines and distinct proteins become unstable and can accumulate as protein aggregates inside and outside of cells. Both in disease and during aging, proteins selectively aggregate in certain tissues and not others. Yet, tissue-specific regulation of cytoplasmic...

Full description

Bibliographic Details
Main Authors: Raimund Jung, Marie C Lechler, Ana Fernandez-Villegas, Chyi Wei Chung, Harry C Jones, Yoon Hee Choi, Maximilian A Thompson, Christian Rödelsperger, Waltraud Röseler, Gabriele S Kaminski Schierle, Ralf J Sommer, Della C David
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-09-01
Series:PLoS Biology
Online Access:https://doi.org/10.1371/journal.pbio.3002284
_version_ 1797680694747463680
author Raimund Jung
Marie C Lechler
Ana Fernandez-Villegas
Chyi Wei Chung
Harry C Jones
Yoon Hee Choi
Maximilian A Thompson
Christian Rödelsperger
Waltraud Röseler
Gabriele S Kaminski Schierle
Ralf J Sommer
Della C David
author_facet Raimund Jung
Marie C Lechler
Ana Fernandez-Villegas
Chyi Wei Chung
Harry C Jones
Yoon Hee Choi
Maximilian A Thompson
Christian Rödelsperger
Waltraud Röseler
Gabriele S Kaminski Schierle
Ralf J Sommer
Della C David
author_sort Raimund Jung
collection DOAJ
description During aging, proteostasis capacity declines and distinct proteins become unstable and can accumulate as protein aggregates inside and outside of cells. Both in disease and during aging, proteins selectively aggregate in certain tissues and not others. Yet, tissue-specific regulation of cytoplasmic protein aggregation remains poorly understood. Surprisingly, we found that the inhibition of 3 core protein quality control systems, namely chaperones, the proteasome, and macroautophagy, leads to lower levels of age-dependent protein aggregation in Caenorhabditis elegans pharyngeal muscles, but higher levels in body-wall muscles. We describe a novel safety mechanism that selectively targets newly synthesized proteins to suppress their aggregation and associated proteotoxicity. The safety mechanism relies on macroautophagy-independent lysosomal degradation and involves several previously uncharacterized components of the intracellular pathogen response (IPR). We propose that this protective mechanism engages an anti-aggregation machinery targeting aggregating proteins for lysosomal degradation.
first_indexed 2024-03-11T23:33:46Z
format Article
id doaj.art-6e413ad3f27943b5974f39bac00f3cda
institution Directory Open Access Journal
issn 1544-9173
1545-7885
language English
last_indexed 2024-03-11T23:33:46Z
publishDate 2023-09-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Biology
spelling doaj.art-6e413ad3f27943b5974f39bac00f3cda2023-09-20T05:31:04ZengPublic Library of Science (PLoS)PLoS Biology1544-91731545-78852023-09-01219e300228410.1371/journal.pbio.3002284A safety mechanism enables tissue-specific resistance to protein aggregation during aging in C. elegans.Raimund JungMarie C LechlerAna Fernandez-VillegasChyi Wei ChungHarry C JonesYoon Hee ChoiMaximilian A ThompsonChristian RödelspergerWaltraud RöselerGabriele S Kaminski SchierleRalf J SommerDella C DavidDuring aging, proteostasis capacity declines and distinct proteins become unstable and can accumulate as protein aggregates inside and outside of cells. Both in disease and during aging, proteins selectively aggregate in certain tissues and not others. Yet, tissue-specific regulation of cytoplasmic protein aggregation remains poorly understood. Surprisingly, we found that the inhibition of 3 core protein quality control systems, namely chaperones, the proteasome, and macroautophagy, leads to lower levels of age-dependent protein aggregation in Caenorhabditis elegans pharyngeal muscles, but higher levels in body-wall muscles. We describe a novel safety mechanism that selectively targets newly synthesized proteins to suppress their aggregation and associated proteotoxicity. The safety mechanism relies on macroautophagy-independent lysosomal degradation and involves several previously uncharacterized components of the intracellular pathogen response (IPR). We propose that this protective mechanism engages an anti-aggregation machinery targeting aggregating proteins for lysosomal degradation.https://doi.org/10.1371/journal.pbio.3002284
spellingShingle Raimund Jung
Marie C Lechler
Ana Fernandez-Villegas
Chyi Wei Chung
Harry C Jones
Yoon Hee Choi
Maximilian A Thompson
Christian Rödelsperger
Waltraud Röseler
Gabriele S Kaminski Schierle
Ralf J Sommer
Della C David
A safety mechanism enables tissue-specific resistance to protein aggregation during aging in C. elegans.
PLoS Biology
title A safety mechanism enables tissue-specific resistance to protein aggregation during aging in C. elegans.
title_full A safety mechanism enables tissue-specific resistance to protein aggregation during aging in C. elegans.
title_fullStr A safety mechanism enables tissue-specific resistance to protein aggregation during aging in C. elegans.
title_full_unstemmed A safety mechanism enables tissue-specific resistance to protein aggregation during aging in C. elegans.
title_short A safety mechanism enables tissue-specific resistance to protein aggregation during aging in C. elegans.
title_sort safety mechanism enables tissue specific resistance to protein aggregation during aging in c elegans
url https://doi.org/10.1371/journal.pbio.3002284
work_keys_str_mv AT raimundjung asafetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT marieclechler asafetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT anafernandezvillegas asafetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT chyiweichung asafetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT harrycjones asafetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT yoonheechoi asafetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT maximilianathompson asafetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT christianrodelsperger asafetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT waltraudroseler asafetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT gabrieleskaminskischierle asafetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT ralfjsommer asafetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT dellacdavid asafetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT raimundjung safetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT marieclechler safetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT anafernandezvillegas safetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT chyiweichung safetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT harrycjones safetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT yoonheechoi safetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT maximilianathompson safetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT christianrodelsperger safetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT waltraudroseler safetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT gabrieleskaminskischierle safetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT ralfjsommer safetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans
AT dellacdavid safetymechanismenablestissuespecificresistancetoproteinaggregationduringagingincelegans